Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...

These findings were published in August 2025, in Cardiovascular Revascularization Medicine.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the presentation of new ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS) ...

Doctronic reports a 24% spike in heart attacks after the spring time change due to sleep disruption, stressing the need for ...

The clock is, once again, going ahead by an hour. While "springing forward" might seem easy, it's a good idea to know the consequences that come with a lack of sleep.

That's a big leap over a relatively short period, and the trend offers a significant opportunity for medical device makers, ...

While each person may experience unique symptoms for different illnesses, most people develop symptoms that are considered common (e.g., sneezing, coughing, and a runny nose for a cold). So when ...

Ambiq Micro, Inc. ("Ambiq®"), a leader in ultra-low-power semiconductor solutions for edge AI, today revealed new technical details of its upcoming Atomiqtm SoC. Built on Ambiq's newly designed 12nm ...

The 'Beverly Hills, 90210' star died at age 52 in March 2019, just days after suffering a massive stroke — but his legacy ...

The Canadian province of British Columba is making the switch to permanent Daylight Saving Time.

SLN, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and ...